Viatris

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Viatris is expanding its innovative medicines strategy by acquiring Pacira BioSciences for $1.65 billion to lead in non-opioid pain therapies.

9 sources 9 articles v 34 39m ago

\n \n \n

\n \n \n \n